ノースカロライナにおける結腸癌の臨床試験
ノースカロライナ内の拠点で、結腸癌に関する20件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- Southeastern Medical Oncology Center-Clinton, Clinton
- CaroMont Regional Medical Center, Gastonia
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- 他2件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- WakeMed Raleigh Campus ( Site 0094), Raleigh
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Duke Cancer Center Cary, Cary
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Messino Cancer Center, Asheville
- The University of North Carolina At Chapel Hill, Chapel Hill
- Oncology Specialists of Charlotte, Charlotte
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UNC- Chapel Hill, Chapel Hill
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- First Health of the Carolinas, Pinehurst
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Duke Cancer Center Cary, Cary
- UNC Health Cancer Care Cary, Cary
- Waverly Hematology Oncology, Cary
- 他22件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Shield Post-Approval Study Protocol
- Cary Gastroenterology Associates, Cary
- University of North Carolina at Chapel Hill, Chapel Hill
- University of North Carolina at Chapel Hill, Chapel Hill
- 他1件
被験者募集中観察研究健康なボランティア歓迎
45歳〜81歳 · 全性別 · 2026/08/07更新 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Charlotte
- Xencor Investigative Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Durham
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
- Virtual Research Group, Morrisville
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2025/08/12更新 · NCT06864338APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。